<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01382823</url>
  </required_header>
  <id_info>
    <org_study_id>FEMTO 2010</org_study_id>
    <nct_id>NCT01382823</nct_id>
  </id_info>
  <brief_title>Laser Cataract Surgery With the Femtosecond Laser Technology</brief_title>
  <official_title>Laser Cataract Surgery With the Femtosecond Laser Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Innovative Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Innovative Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to prove the efficacy and safety of the Femtosecond laser to
      create a clear corneal incision during cataract surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular Pressure</measure>
    <time_frame>three month</time_frame>
    <description>Measure the fluid pressure inside the eye.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Uncorrected and Best corrected Visual Acuity</measure>
    <time_frame>three month</time_frame>
    <description>Vision obtained with the best possible lens correction (Best corrected). Vision obtained without the use of glasses or contact lenses (Uncorrected).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Cataracts</condition>
  <arm_group>
    <arm_group_label>Femtosecond Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Femtosecond Laser</intervention_name>
    <description>Using the Femtosecond Laser to make a clear corneal incision.</description>
    <arm_group_label>Femtosecond Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Study participants must have a cataract for which phacoemulsification extraction and
             posterior IOL implantation has been planned in at least one eye.

          -  Study participants should be capable of achieving better than 20/30 Snellen best
             corrected distance vision after cataract extraction and IOL implantation.

          -  The surgeon may use the Mento Potential Acuity Meter (PAM)laser interferometer,
             McIntyre Pinhole, or his/her judgement to estimate the patient's potential acuity.

        Exclusion Criteria:

          -  Concurrent participation or participation in the last 30 days in other clinical
             trials.

          -  Known steroid IOP responder.

          -  Taking medications that may affect vision, IOP, or ease of cataract surgery (e.g.
             Flomax, Glaucoma medications, etc.).

          -  Acute or chronic disease or illness that would increase risk or confound study
             results(e.g. uncontrolled diabetes mellitus, immunocompromised, etc.).

          -  Uncontrolled systemic or ocular disease.

          -  Corneal abnormalities (e.g. stromal, epithelial, or endothelial dystrophies)

          -  Pseudoexfoliation.

          -  Ocular hypertension (&gt;or =20hg) or glaucomatous changes in the optic nerve.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Loden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loden Vision Centers</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loden Vision Centers</name>
      <address>
        <city>Goodlettsville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2011</study_first_submitted>
  <study_first_submitted_qc>June 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2011</study_first_posted>
  <last_update_submitted>October 5, 2011</last_update_submitted>
  <last_update_submitted_qc>October 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Melissa Earl</name_title>
    <organization>CRO</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

